IS6928A - Aðferðir til að framleiða mirtasapínmilliefni - Google Patents

Aðferðir til að framleiða mirtasapínmilliefni

Info

Publication number
IS6928A
IS6928A IS6928A IS6928A IS6928A IS 6928 A IS6928 A IS 6928A IS 6928 A IS6928 A IS 6928A IS 6928 A IS6928 A IS 6928A IS 6928 A IS6928 A IS 6928A
Authority
IS
Iceland
Prior art keywords
mirtasapine
intermediates
producing
methods
producing mirtasapine
Prior art date
Application number
IS6928A
Other languages
English (en)
Inventor
Metzger Leonid
Wizel Shlomit
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS6928A publication Critical patent/IS6928A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6928A 2001-03-01 2003-08-27 Aðferðir til að framleiða mirtasapínmilliefni IS6928A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27269901P 2001-03-01 2001-03-01
PCT/US2002/004340 WO2002070513A1 (en) 2001-03-01 2002-02-14 Methods for the preparation of mirtazapine intermediates

Publications (1)

Publication Number Publication Date
IS6928A true IS6928A (is) 2003-08-27

Family

ID=23040907

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6928A IS6928A (is) 2001-03-01 2003-08-27 Aðferðir til að framleiða mirtasapínmilliefni

Country Status (10)

Country Link
US (1) US6774230B2 (is)
EP (1) EP1370549A4 (is)
JP (1) JP2005501808A (is)
KR (1) KR20030078086A (is)
CA (1) CA2438446A1 (is)
IL (1) IL157607A0 (is)
IS (1) IS6928A (is)
NO (1) NO20033840D0 (is)
PL (1) PL374044A1 (is)
WO (1) WO2002070513A1 (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
EP1370549A4 (en) 2005-03-09
PL374044A1 (en) 2005-09-19
KR20030078086A (ko) 2003-10-04
WO2002070513A9 (en) 2002-11-21
JP2005501808A (ja) 2005-01-20
CA2438446A1 (en) 2002-02-14
WO2002070513A1 (en) 2002-09-12
US6774230B2 (en) 2004-08-10
US20020165238A1 (en) 2002-11-07
EP1370549A1 (en) 2003-12-17
IL157607A0 (en) 2004-03-28
NO20033840D0 (no) 2003-08-29

Similar Documents

Publication Publication Date Title
DE60205413D1 (de) Herstellungsverfahren
BRPI0313238A2 (pt) método
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
ATE360674T1 (de) Hydrierverfahren
DE60233109D1 (de) Radidentifikator- ortungsverfahren
IS6716A (is) Aðferðir við að framleiða sílostasól
ITMI20021031A0 (it) Procedimento per preparare policarbonato-polioli
IS6928A (is) Aðferðir til að framleiða mirtasapínmilliefni
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE60207451D1 (de) Produktionsverfahren
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner
FI20011252A0 (fi) Rakennusmenetelmä
DE50115802D1 (de) Dafür
ITMI20020240A0 (it) Metodo per fabbricare un oggetto ornamentale
SE0104471D0 (sv) New method
ITMI20042151A1 (it) Procedimento per produrre acquavite
SE0103357D0 (sv) New method
SE0103416D0 (sv) New method
SE0103573D0 (sv) New method
SE0104227D0 (sv) New method
SE0201055D0 (sv) New method
SE0102004L (sv) Indiviva-metoden
DOP2001000312A (es) Metodo
SE0101479D0 (sv) Method
SE0100900D0 (sv) Method